Inhibition of gastric secretion by anti-gastrinic and H2-blocking agents.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001549:Benzamides / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D005750:Gastric Juice / Q000378:metabolism*; D005973:Glutamine / Q000031:analogs & derivatives*; D006168:Guinea Pigs; D006633:Histamine Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008785:Metiamide / Q000494:pharmacology; D010418:Pentagastrin / Q000494:pharmacology; D010437:Peptic Ulcer / Q000188:drug therapy; D011377:Proglumide / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D012636:Secretory Rate / Q000187:drug effects; D014364:Tryptophan / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D001549:Benzamides; D006633:Histamine Antagonists; D005973:Glutamine; D008785:Metiamide; D001285:Atropine; D014364:Tryptophan; D010418:Pentagastrin; D011377:Proglumide